BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:In the context of intense scrutiny over the safety and durabil
 ity of blood disease-targeted gene therapies and a flurry of excitement a
 round novel gene editing technologies\, the 3rd Gene Therapy for Blood Di
 sorders Summit will unite the leading large pharma and innovative biotech
 s to share essential learnings from across this rapidly evolving field\, 
 enabling you to progress your pipeline to address the significant unmet n
 eed in this field.\n\nFocused specifically on hemophilia\, beta-thallasem
 ia and sickle cell-directed gene therapies and gene editing approaches\, 
 this event is an invaluable opportunity to learn the realities of durabil
 ity challenges\, understand strategies to guarantee safety at every stage
  of development and get a head-start in understanding the most promising 
 technologies set to revolutionise the field.\n\nIncorporating insights fr
 om translational\, clinical and commercial industry experts\, as well as 
 leading clinicians actively involved in late-stage trials\, this is your 
 opportunity to investigate the realities of managing immunogenicity for s
 ystemically administered gene therapies\, establishing less cytotoxic con
 ditioning regimens for ex vivo approaches and prepare for the commercial 
 reality of launching a gene therapy and ensuring there is widespread pati
 ent adoption.\n
DTEND:20220331T174000
DTSTAMP:20260512T232259Z
DTSTART:20220329T085000
LOCATION:Online\, \,
SEQUENCE:0
SUMMARY:In the context of intense scrutiny over the safety and durability 
 of blood disease-targeted gene therapies and a flurry of excitement aroun
 d novel...
UID:ce4590f3-d8fb-49de-a561-fe05a3c2da8f
END:VEVENT
END:VCALENDAR